On Monday
October 1st in Paris, Aviesan has signed a memorandum of understanding with the
National Innovation Agency of Thailand. This important event should help to
disseminate HTech4Dev in Southern Asia. A workshop co-funded by NIA and Aviesan
will be organized next year in Thailand to select some projects of health tech
implementation in some of the neighbouring countries of Thailand.
Friday, October 5, 2012
Friday, June 15, 2012
2012 EU/Member States-India Joint Stakeholders' Conference
The Indo-European Partnership for Research and Innovation
We were invited to present the “HTech4Dev” initiative as part of the parallel session dedicated to health issues (including new pharmaceutical drugs, medical technologies and instrumentation) co-chaired by Mr. Kari Komulainen, Director, International Network, Tekes (Finland) and Dr. Selvamurthy, Chief Controller, Research and Development, Defence Research and Development Organisation (India). Several crucial issues were raised to assess the transfer to LMICs of heath technologies developed in Indian who developed state of the art technologies in this area. This could help those countries to solve health disparities among their population: contacts have been established to hopefully set up new collaborations.
The conference presentations have been posted at:
http://ec.europa.eu/research/iscp/index.cfm?pg=india-eu-conference-2012
We had the great
chance to attend the “Indo-European Research and Innovation Partnership”. This
conference was organized by the European Commission in Brussels (May 30th,
June 1st). As described in the invitation note, “the main objective
of the forthcoming conference was to mobilise Indian and European stakeholders and define a shared EU/Member
States-India strategic agenda by identifying common challenges, priority areas
and instruments for future action.”
We were invited to present the “HTech4Dev” initiative as part of the parallel session dedicated to health issues (including new pharmaceutical drugs, medical technologies and instrumentation) co-chaired by Mr. Kari Komulainen, Director, International Network, Tekes (Finland) and Dr. Selvamurthy, Chief Controller, Research and Development, Defence Research and Development Organisation (India). Several crucial issues were raised to assess the transfer to LMICs of heath technologies developed in Indian who developed state of the art technologies in this area. This could help those countries to solve health disparities among their population: contacts have been established to hopefully set up new collaborations.
The conference presentations have been posted at:
http://ec.europa.eu/research/iscp/index.cfm?pg=india-eu-conference-2012
Tuesday, May 22, 2012
Meeting AMREF about our project in Senegal
AMREF is an
international African organization headquartered in Nairobi, Kenya.
We had the
great opportunity to meet with two representatives of AMREF in Paris: Dr Mor
NGOM, Program Coordinator in West Africa (Senegal) and Silvia TOLVE in charge
of programs in France.
We were
mostly interested in their experience with telemedicine in Senegal. They used
to work with the telemedicine service, part of the Minsitry of Health, and are
willing to pursue their collaboration to share their experience and expertise:
a reference center has been built in Dakar and several projects have been set
up with local hospitals to develop e-health in the area. A convention has been
prepared with the previous government and should be discussed again soon.
AMREF was
also involved in the SAHEL project led by European Space Agency (ESA) in Kenya.
The SAHEL project proposes an efficient cooperation between technological
players (industries, operators), health stakeholders (health workers, nurses,
specialists...), centers of excellence providing medical content for eLearning
and NGOs for local implementation with the support of regional actors.
We agreed
to collaborate on the construction of the telemedicine project in Senegal with
Prof. Mbayang NDIAYE NIANG and the new Ministry of Health led by Prof. Awa
Marie COLL SECK. Moreover, we plan to work together on other proposals by
sharing expertise and network.
Tuesday, May 15, 2012
Back from Forum 2012 in Cape Town, SA
With the support
from COHRED Group (Geneva), Aviesan held a session on Health Technology
Transfer, as part of the Global Forum 2012. It was of course an opportunity to
present HTech4Dev program and progress, but the main purpose of the session was
to focus on the necessary (contextual
and pragmatic) elements for the transfer
of health technologies toward Low and Middle Income Countries (LMICs). Topics related to health technologies (infrastructure,
developmental challenges, market and regulatory acceptance) were presented and
discussed. In addition, boarder topics
of intellectual property, jurisdictional approaches, social acceptance and
impact were presented and discussed. Thanks to all of our speakers who
travelled from far away (Bangladesh, Canada, Europe and Thailand) to share with
the audience their experience in the use
of new technologies to fill the gap between developed and under-developed
economies.
During the first part of the session, the orators nicely pictured the great promises of some nano-based technologies as solutions to basic human health problems. Some presenters described regional examples/challenges for the successful implementation and use of tele-medicine. An informative and enlightening lecture given by the President of the European Group on Ethics who provided some clues on how Africa may better valorize by building an environment prone to protect Africa generated intellectual property. A presentation by WHO (World Health Organization) Assistant Director-General for ‘Innovation, Information, Evidence and Research’ detailed success, and evidenced that local production of therapeutics in Africa can be viable. Participants from several key organizations were present and contributed to the stimulating discussions. Representatives from IFPMA (the International Federation of Pharmaceutical Manufacturers & Association) and WIPO (World Intellectual Property Organization) illustrated the specificity and challenges to be addressed on health technologies transfer in LMICs. An outstanding presentation was made by the President of the Cameroon Bioethics Initiative who explained on the African social move needed toward the acceptance of these new technologies.
Judging from the level of participant’s engagement and discussions (going well beyond the scheduled time, follow-up actions and networking), the session on Health Technology Transfer was a success.
All these presentations will be made available soon on Forum 2012 website (www.forum2012.org).
During the first part of the session, the orators nicely pictured the great promises of some nano-based technologies as solutions to basic human health problems. Some presenters described regional examples/challenges for the successful implementation and use of tele-medicine. An informative and enlightening lecture given by the President of the European Group on Ethics who provided some clues on how Africa may better valorize by building an environment prone to protect Africa generated intellectual property. A presentation by WHO (World Health Organization) Assistant Director-General for ‘Innovation, Information, Evidence and Research’ detailed success, and evidenced that local production of therapeutics in Africa can be viable. Participants from several key organizations were present and contributed to the stimulating discussions. Representatives from IFPMA (the International Federation of Pharmaceutical Manufacturers & Association) and WIPO (World Intellectual Property Organization) illustrated the specificity and challenges to be addressed on health technologies transfer in LMICs. An outstanding presentation was made by the President of the Cameroon Bioethics Initiative who explained on the African social move needed toward the acceptance of these new technologies.
Prof Carel IJsselmuiden, Director COHRED |
Judging from the level of participant’s engagement and discussions (going well beyond the scheduled time, follow-up actions and networking), the session on Health Technology Transfer was a success.
All these presentations will be made available soon on Forum 2012 website (www.forum2012.org).
Dr Jacques Grassi, Director ITS, Aviesan |
Dr Marie-Paule Kieny, WHO Assistant Director-General |
Dr François Hirsch, Aviesan ITS |
Prof. Julian Kinderlerer, Cape Town University |
Tuesday, April 10, 2012
Women and child’s health at stake in Cameroon
Prof. Dieudonné
Adiogo, vice-dean of Douala Pharmaceutical School is setting up a project
dedicated to Women’s Health: Monitoring and treatment of hypocalcemia and
anemia on young women in Cameroon.
This project based on
a new nano-diagnostic device in development will be conducted in two phases:
Phase 1: test and
validation of the new test on 3000 women from the Douala surroundings with
limited health care access.
Phase 2: test and
implementation of the new test in remote areas of Cameroon with limited health
care access.
The project will
contribute to improve the women health by supplementing them in Calicum (Ca)
and Iron (Fe) when needed. New born and infants will also benefit from the
treatment delivered to their pregnant and nursing mothers. With a corrected
level of Ca and Fe, women will feel better and will be able to work in better
conditions, thus having an improved quality of life. This project should
contribute both to women emancipation and life improvement.
The pilot study will
involve students from Douala University: students in human sciences will
contribute to inform, recruit and then follow up on women participating in the study;
students in biology will withdraw the blood samples, perform the newly
designed test in comparison to the available method and be also in charge
of the data processing. A physician will be responsible for clinical
examination and treatment of the patients.
After validation of
the new diagnostic device in these previous steps, it will be tested for
validation in other areas of Cameroon under various climate conditions.
Management and continuation of this part of the project will be discussed with
health authorities of the country and with WHO representatives to disseminate
this new approach to other African countries.
Friday, March 2, 2012
Session moved to Wed April 25th
Please, note that our session will take place on
Wednesday April 25th
from 13:30 to 17:00.
The program remains the same!
Thanks for understanding!
Monday, February 27, 2012
Towards Forum 2012!
Our
Institute has been working with COHRED for one year on the MDGs and health
technologies issues. This led us to contribute to their COHRED-GFHR Forum 2012
to be held in Cape Town, South Africa April 24-26.
This great
event will bring together people from various backgrounds and countries:
scientists, international institution and civil society representatives, NGOs,
health authorities… around 3 themes:
- Theme 1: Improving and increasing investments in research and innovation
- Theme 2: Networking and partnership for research and innovation
- Theme 3: Creating environment that support research and innovation
Aviesan Session – April 25th 2012
Theme 3: Creating
environments that support R&I “Challenges and Successes in the Transfer of technology to low and
middle income countries”
On Thursday April 25th, the
Institute of Health Technologies, part of Aviesan, will lead a session which
will examine the challenges and successes of transferring technology to LMICs . This will be also the opportunity to give an update on HTech4Dev, the international initiative led by the Institute for Health Technologies.
13:30
|
Welcome
|
François HIRSCH, Aviesan
Introduction
|
|
Part 1 – Technologies overview
|
|
13:40
|
Nanotechnologies for Health
François BERGER, Aviesan
Nano-medicine: new business models on high tech medical devices
Rome JUTABHA, National
Innovation Agency, Thailand
Nano-Medicine: The Potential Versus The Pitfalls – A Clinician’s
Perspective
Conor BURKE, Biomedical Diagnostics
Institute, Ireland
Development of Point-of-Care Diagnostic Platforms for Applications in
Global Health
|
14:30
|
Telemedicine
Bram RAMJIAWAN, Saint-Boniface Hospital, Canada
The Canadian model
Zakir M. SIKDER, Telemedicine Reference Center Ltd.,
Bangladesh
The Bangladeshi model
|
15:00-15:30
|
Market Place - Coffee Break -
Priority Setting Café
|
Part 2 – Intellectual Property Issues and Technology
Transfer
|
|
15:00
|
Keynote speech
Julian KINDERLERER, Cape Town
University, E.G.E. Brussels
IP Issues in the context of LMICs
|
15:50
|
Health Technologies for
Development
François HIRSCH, Aviesan
Health Technologies for Development
(HTech4Dev initiative)
Marie-Paule KIENY, WHO Assistant
Director-General ‘ Innovation,
Information, Evidence and Research’
Local production in support of access to medical technologies
|
16:15
|
Round Table : Specificity and
challenges to be addressed on health technologies transfer in LMICs
Chairman:
Jacques GRASSI, CVT Sud, Aviesan; Guests: Konji SEBATI, WIPO – Mario OTTIGLIO, IFPMA Associate
Director, Public Affairs & Global Health – Julian KINDERLERER, Cape Town University, E.G.E. Brussels
|
Part 3 – Civil Society Perspectives
|
|
17:30
|
Keynote speech
Godfrey TANGWA, Yaounde University, Cameroon
Transfer of Technology: telemedicine and
nanotechnologies in the African context, prospects and challenges
|
18:00
|
End of the session
|
We are
looking forward to meeting you there and discussing these crucial issues for
development with you!
Monday, February 6, 2012
Meeting with the Sanofi-Espoir Foundation
We had the pleasure to
meet with the Foundation Managing Director and the Partnership Program Senior
Manager to present our initiative and the projects we support.
Founded on October 2,
2010, by Sanofi-Aventis Group, the Sanofi Espoir Corporate Foundation is tasked
with supporting actions of general interest in the healthcare field on an
international scale.
The Foundation's
mission is to contribute to reducing health inequalities, particularly among
the most needy, by focusing on key issues in prevention, training and access to
care.
Talking about health
and development with them made us realize how important it is to work on the
project construction to come up with strong partnerships between the technology
implementation and the local network to be set up around the targeted
population.
Sanofi-Espoir
Foundation could thus support projects aiming at improving access to healthcare
and involving community healthcare people. These projects actually need to
follow strict criteria to be considered: see their Guidelines to select
projects. Projects involving vaccines or medicines will be be considered by Sanofi Coporate or Sanofi-Pasteur.
As far as our
HTech4Dev Initiative is concerned, two projects might fit in the Foundation
scope:
- Cameroon: Anemia and Calcemia monitoring and treatment for adult women in Douala area.
- Senegal: Medical Record System
To allow these
projects to meet the Foundation criteria, for each we have established a
multi-disciplinary steering committee with 2 clear tasks:
- helping to identify the best relevant technology;
- helping to present a solid structure with an active local healthcare network aiming at facilitating the social acceptance of the new devices.
- helping to identify the best relevant technology;
- helping to present a solid structure with an active local healthcare network aiming at facilitating the social acceptance of the new devices.
Subscribe to:
Posts (Atom)